4.6 • 3.5K Ratings
🗓️ 13 July 2022
⏱️ 51 minutes
🧾️ Download transcript
Reinfections across the country are being driven by an explosion in cases of BA.5, the latest variant of COVID-19. Andy asks Harvard epidemiologist Bill Hanage whether our vaccines and immune systems have a fighting chance, if infections are more severe than other Omicron offshoots, and what we need to do to safely get through the summer and fall. Will those who have managed to avoid the virus for years finally succumb to this wave? Find out.
Keep up with Andy on Twitter @ASlavitt.
Follow Bill Hanage on Twitter @BillHanage.
Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.
Support the show by checking out our sponsors!
Check out these resources from today’s episode:
Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.
For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.
See omnystudio.com/listener for privacy information.
Click on a timestamp to play from that location
0:00.0 | It's CVS Health, they know the women's physical, mental, and sexual health matters. |
0:05.0 | That's why they're offering new women's health services available nationwide seven days a week. |
0:09.0 | From heart health, blood pressure, and cholesterol screenings available at miniclinic locations, |
0:14.0 | to virtual birth control consultations and visits with a board certified provider, |
0:18.0 | women's health is it an afterthought. It matters. |
0:21.0 | It's CVS Health. Health here happens together. Learn more at CVSHealth.com. |
0:27.0 | What will your golden ears look like? On Lemonade Media's new series Being Golden, |
0:33.0 | here from four unique seniors who are navigating all of life's triumphs, struggles, and even heart breaks. |
0:38.0 | Step into their world as they chase their passions, make new connections, reflect on their experiences, |
0:43.0 | and even throw some shade. It's reality TV for your ears, an opportunity to be someone else in their prime. |
0:50.0 | Being Golden is the newest production from Lemonade Media's Being Studios. |
0:54.0 | Listen to all six episodes of Being Golden, wherever you listen to podcasts. |
0:58.0 | Lemonade. |
1:01.0 | Now, come on out. |
1:23.0 | Welcome to the bubble. This is your host Andy Slavitt. |
1:26.0 | It's Wednesday, July 13th. How are you doing? We have an episode today that's going to focus squarely on what's the evolving picture looks like from the BA5 |
1:38.0 | variant as it makes its presence known here in the US. To do that, we have on the show the same person that I invite on every time we have a new variant with Omicron, |
1:48.0 | Bill Hanich from Harvard. Bill is a delight. You're really going to get a lot out of this show. We're going to get right into it. |
1:57.0 | But let me take you to get a little bit of a painting of the picture for you. BA5, along with BA4, but I think BA5 is the more relevant and stronger of the two. |
2:08.0 | We're making it way around the country, infecting a lot of people, particularly so in the south, starting to hit Florida, and we've got a lot of open questions. My most important questions are number one, what's happening to our immune system? |
2:24.0 | What's happening to our immune system? Is our prior immunity holding or is BA5 dodging it? I think there's a lot to be learned there and going to go there with Bill. |
2:32.0 | Secondly, is this thing more severe? We get some mixed data from different parts of the world. Some of which says it might be more severe, some of which says it might not. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Lemonada Media, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Lemonada Media and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.